Key points are not available for this paper at this time.
Introduction Malaria pathogenesis involves both parasite burden and host inflammatory and oxidative stress responses that contribute to haematological alterations. Full blood count (FBC)-derived indices have been explored as accessible surrogate biomarkers, reflecting systemic inflammatory changes; however, they provide limited mechanistic insight into underlying haem-driven oxidative stress pathways. Haem oxygenase-1 (HO-1) reflects cellular responses to free haem, while interleukin-6 (IL-6) mediates systemic inflammation. However, their combined role in relation to parasitaemia and haematological alterations in endemic populations remains insufficiently defined. This study evaluated plasma HO-1 and IL-6 as complementary host-response biomarkers in a hospital-based malaria-endemic population. Methods This cross-sectional study was conducted at Covenant University Medical Centre (CUMC), Canaanland, Ota, Ogun State, Nigeria. A total of 647 individuals were screened, and 304 participants with complete microscopy and haematological data were retained in the analytical cohort (152 microscopy-positive and 152 microscopy-negative). An integrated biomarker subset of 40 participants with matched plasma samples and complete laboratory data was used for ELISA, correlation, and receiver operating characteristic (ROC) analyses. Group comparisons used Mann-Whitney U and Kruskal-Wallis tests, categorical variables were compared using chi-square or Fisher exact tests, and associations were assessed using Spearman correlation. Results In the analytical cohort, microscopy-positive participants had lower haemoglobin, haematocrit, red-cell count, mean cell indices, and platelet counts, together with higher temperature and white-cell counts than microscopy-negative participants (all p 0.001 for the major contrasts). Fever and anaemia were also substantially more frequent in microscopy-positive participants. In the biomarker subset, IL-6 was significantly higher in malaria-positive participants than malaria-negative participants (median 141.28 vs 106.58 pg/mL; p = 0.027), whereas HO-1 showed a non-significant upward shift (230.98 vs 193.73 ng/mL; p = 0.131). IL-6 correlated positively with HO-1 (rho = 0.702, p 0.001), parasitaemia (rho = 0.387, p = 0.015), and temperature (rho = 0.432, p = 0.006), and negatively with haemoglobin (rho = -0.417, p = 0.008). ROC analysis showed moderate discriminatory performance for IL-6 and lower performance for HO-1. IL-6 yielded an AUC of 0.709 (95% CI 0.531–0.874), with sensitivity of 72.7% and specificity of 76.5% at the Youden-optimal threshold. HO-1 yielded an AUC of 0.641 (95% CI 0.440–0.826), while the combined IL-6 + HO-1 model yielded an AUC of 0.687 (95% CI 0.461–0.886). Conclusions IL-6 showed better discriminatory performance than HO-1 in this cohort, while HO-1 demonstrated only modest and non-significant differences between groups. These findings suggest that IL-6 may be a more informative adjunct inflammatory marker in malaria, whereas the role of HO-1 requires further validation in larger studies.
Wakai et al. (Fri,) studied this question.